Click here to get full coverage on Biovie Stock Price Forecast. Should You Buy BIVI? - StockInvest.us

Biovie Stock Price Forecast. Should You Buy BIVI?  StockInvest.us

Biovie Stock Price Forecast. Should You Buy BIVI? - StockInvest.us

Click here to get full coverage on Cumulus Mosquito Bivi Review: Cowboy Glamping - bikepacking.com

Cumulus Mosquito Bivi Review: Cowboy Glamping  bikepacking.com

Cumulus Mosquito Bivi Review: Cowboy Glamping - bikepacking.com

Click here to get full coverage on Jane Street Group Expands BioVie Inc (BIVI) Stake by Over 1,100% - GuruFocus

Jane Street Group Expands BioVie Inc (BIVI) Stake by Over 1,100%  GuruFocus

Jane Street Group Expands BioVie Inc (BIVI) Stake by Over 1,100% - GuruFocus

Click here to get full coverage on Insider Purchase: Chief Medical Officer of $BIVI Buys 4,843 Shares - Quiver Quantitative

Insider Purchase: Chief Medical Officer of $BIVI Buys 4,843 Shares  Quiver Quantitative

Insider Purchase: Chief Medical Officer of $BIVI Buys 4,843 Shares - Quiver Quantitative

Click here to get full coverage on BioVie seeks FDA feedback on a proposed Parkinson’s trial of about 175 patients. - Stock Titan

BioVie seeks FDA feedback on a proposed Parkinson’s trial of about 175 patients.  Stock Titan

BioVie seeks FDA feedback on a proposed Parkinson’s trial of about 175 patients. - Stock Titan

Click here to get full coverage on BioVie advances Parkinson’s Phase 3 development program with FDA engagement - Proactive financial news

BioVie advances Parkinson’s Phase 3 development program with FDA engagement  Proactive financial news

BioVie advances Parkinson’s Phase 3 development program with FDA engagement - Proactive financial news

Click here to get full coverage on Biovie director Amy Chappell acquires $1,570 in BIVI common stock - Investing.com

Biovie director Amy Chappell acquires $1,570 in BIVI common stock  Investing.com

Biovie director Amy Chappell acquires $1,570 in BIVI common stock - Investing.com

Click here to get full coverage on BioVie (BIVI) Jumps As SUNRISE-PD Data Fuel Bullish Hopes - StocksToTrade

BioVie (BIVI) Jumps As SUNRISE-PD Data Fuel Bullish Hopes  StocksToTrade

BioVie (BIVI) Jumps As SUNRISE-PD Data Fuel Bullish Hopes - StocksToTrade

Click here to get full coverage on BIVI Stock Pops As SUNRISE-PD Parkinson’s Data Fuel Hype - timothysykes.com

BIVI Stock Pops As SUNRISE-PD Parkinson’s Data Fuel Hype  timothysykes.com

BIVI Stock Pops As SUNRISE-PD Parkinson’s Data Fuel Hype - timothysykes.com

Click here to get full coverage on BioVie (NASDAQ: BIVI) CMO boosts stake with open-market share buy - Stock Titan

BioVie (NASDAQ: BIVI) CMO boosts stake with open-market share buy  Stock Titan

BioVie (NASDAQ: BIVI) CMO boosts stake with open-market share buy - Stock Titan

Click here to get full coverage on $BIVI stock is up 9% today. Here's what we see in our data. - Quiver Quantitative

$BIVI stock is up 9% today. Here's what we see in our data.  Quiver Quantitative

$BIVI stock is up 9% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on BioVie (BIVI) CFO raises holdings to 3,441 shares - Stock Titan

BioVie (BIVI) CFO raises holdings to 3,441 shares  Stock Titan

BioVie (BIVI) CFO raises holdings to 3,441 shares - Stock Titan

Click here to get full coverage on Jane Street reports over 5% stake in BioVie (BIVI) - Stock Titan

Jane Street reports over 5% stake in BioVie (BIVI)  Stock Titan

Jane Street reports over 5% stake in BioVie (BIVI) - Stock Titan

Click here to get full coverage on BioVie (BIVI) director makes open-market share purchase - Stock Titan

BioVie (BIVI) director makes open-market share purchase  Stock Titan

BioVie (BIVI) director makes open-market share purchase - Stock Titan

Click here to get full coverage on BioVie Stock (BIVI) Opinions on Phase 2 Trial Results - Quiver Quantitative

BioVie Stock (BIVI) Opinions on Phase 2 Trial Results  Quiver Quantitative

BioVie Stock (BIVI) Opinions on Phase 2 Trial Results - Quiver Quantitative

Click here to get full coverage on BIOVIE ($BIVI) Releases Q3 2026 Earnings | BIVI Stock News - Quiver Quantitative

BIOVIE ($BIVI) Releases Q3 2026 Earnings | BIVI Stock News  Quiver Quantitative

BIOVIE ($BIVI) Releases Q3 2026 Earnings | BIVI Stock News - Quiver Quantitative

Click here to get full coverage on BIVI - Finviz

BIVI - Finviz

Click here to get full coverage on BioVie (BIVI) CEO makes 15,210-share open-market buy - Stock Titan

BioVie (BIVI) CEO makes 15,210-share open-market buy  Stock Titan

BioVie (BIVI) CEO makes 15,210-share open-market buy - Stock Titan

Click here to get full coverage on BIVI Forecast — Price Target — Prediction for 2027 - TradingView

BIVI Forecast — Price Target — Prediction for 2027  TradingView

BIVI Forecast — Price Target — Prediction for 2027 - TradingView

Click here to get full coverage on BIVI Stock Draws Attention After Strong Parkinson’s Data - StocksToTrade

BIVI Stock Draws Attention After Strong Parkinson’s Data  StocksToTrade

BIVI Stock Draws Attention After Strong Parkinson’s Data - StocksToTrade

Click here to get full coverage on BioVie Announces Update to Parkinson’s Phase 3 Development Program - markets.businessinsider.com

BioVie Announces Update to Parkinson’s Phase 3 Development Program  markets.businessinsider.com

BioVie Announces Update to Parkinson’s Phase 3 Development Program - markets.businessinsider.com

Click here to get full coverage on Edi Bivi - Transfermarkt

Edi Bivi - Transfermarkt

Click here to get full coverage on BIVI Stock Slides As New Equity Offering Looms Over Traders - StocksToTrade

BIVI Stock Slides As New Equity Offering Looms Over Traders  StocksToTrade

BIVI Stock Slides As New Equity Offering Looms Over Traders - StocksToTrade

Click here to get full coverage on BioVie Announces Completion of ADDRESS-LC Phase 2 Trial of Bezisterim in Long COVID, Topline Data Expected in September 2026 - Quiver Quantitative

BioVie Announces Completion of ADDRESS-LC Phase 2 Trial of Bezisterim in Long COVID, Topline Data Expected in September 2026  Quiver Quantitative

BioVie Announces Completion of ADDRESS-LC Phase 2 Trial of Bezisterim in Long COVID, Topline Data Expected in September 2026 - Quiver Quantitative

Click here to get full coverage on BIVI Stock Jumps As SUNRISE-PD Data Fire Up Parkinson’s Hopes - StocksToTrade

BIVI Stock Jumps As SUNRISE-PD Data Fire Up Parkinson’s Hopes  StocksToTrade

BIVI Stock Jumps As SUNRISE-PD Data Fire Up Parkinson’s Hopes - StocksToTrade

Click here to get full coverage on BioVie Inc. Revenue Breakdown – NASDAQ:BIVI - TradingView

BioVie Inc. Revenue Breakdown – NASDAQ:BIVI  TradingView

BioVie Inc. Revenue Breakdown – NASDAQ:BIVI - TradingView

Click here to get full coverage on BioVie completes final patient visit in Phase 2 Long COVID trial - Proactive financial news

BioVie completes final patient visit in Phase 2 Long COVID trial  Proactive financial news

BioVie completes final patient visit in Phase 2 Long COVID trial - Proactive financial news

Click here to get full coverage on Insider Stock Purchases: August 29, 2026 | OPTU Stock News - Quiver Quantitative

Insider Stock Purchases: August 29, 2026 | OPTU Stock News  Quiver Quantitative

Insider Stock Purchases: August 29, 2026 | OPTU Stock News - Quiver Quantitative

Click here to get full coverage on BioVie completes enrollment in Phase 2 Long COVID trial | NASDAQ:BIVI, NASDAQ:BIVIW - Proactive financial news

BioVie completes enrollment in Phase 2 Long COVID trial | NASDAQ:BIVI, NASDAQ:BIVIW  Proactive financial news

BioVie completes enrollment in Phase 2 Long COVID trial | NASDAQ:BIVI, NASDAQ:BIVIW - Proactive financial news

Click here to get full coverage on BioVie completes final patient visit in Parkinson's drug trial - Proactive financial news

BioVie completes final patient visit in Parkinson's drug trial  Proactive financial news

BioVie completes final patient visit in Parkinson's drug trial - Proactive financial news

Click here to get full coverage on New to The Street Broadcasts Today Across Bloomberg Television U.S., Latin America and MENA at 6:30 PM ET - Newswire.com

New to The Street Broadcasts Today Across Bloomberg Television U.S., Latin America and MENA at 6:30 PM ET  Newswire.com

New to The Street Broadcasts Today Across Bloomberg Television U.S., Latin America and MENA at 6:30 PM ET - Newswire.com

Click here to get full coverage on Should I buy BioVie (BIVI) - Zacks Investment Research

Should I buy BioVie (BIVI)  Zacks Investment Research

Should I buy BioVie (BIVI) - Zacks Investment Research

Click here to get full coverage on BioVie CEO shares insights into long COVID trial - ICYMI - Proactive financial news

BioVie CEO shares insights into long COVID trial - ICYMI  Proactive financial news

BioVie CEO shares insights into long COVID trial - ICYMI - Proactive financial news

Click here to get full coverage on BioVie: Long COVID trial fully enrolled – ICYMI - Proactive financial news

BioVie: Long COVID trial fully enrolled – ICYMI  Proactive financial news

BioVie: Long COVID trial fully enrolled – ICYMI - Proactive financial news

Click here to get full coverage on BioVie Inc. CEO Cuong V Do buys $31,636 in company stock - Investing.com

BioVie Inc. CEO Cuong V Do buys $31,636 in company stock  Investing.com

BioVie Inc. CEO Cuong V Do buys $31,636 in company stock - Investing.com

Click here to get full coverage on Join BioVie’s Exclusive Live Investor Webinar and Q and A Session on June 2 - GlobeNewswire

Join BioVie’s Exclusive Live Investor Webinar and Q and A Session on June 2  GlobeNewswire

Join BioVie’s Exclusive Live Investor Webinar and Q and A Session on June 2 - GlobeNewswire

Click here to get full coverage on Best bivvy bags for 2026: Lightweight shelters for solo campers, tested by a backpacking expert - Live for the Outdoors

Best bivvy bags for 2026: Lightweight shelters for solo campers, tested by a backpacking expert  Live for the Outdoors

Best bivvy bags for 2026: Lightweight shelters for solo campers, tested by a backpacking expert - Live for the Outdoors

Click here to get full coverage on New to The Street Broadcasts Show #716 Tonight at 6:30 PM ET on Bloomberg Television Featuring Stardust Power (NASDAQ:SDST), BioVie (NASDAQ:BIVI), Roadzen (NASDAQ:RDZN), with Special Segments from Kelsey Grammer on KAREN and Andrew - Newswire.com

New to The Street Broadcasts Show #716 Tonight at 6:30 PM ET on Bloomberg Television Featuring Stardust Power (NASDAQ:SDST), BioVie (NASDAQ:BIVI), Roadzen (NASDAQ:RDZN), with Special Segments from Kelsey Grammer on KAREN and Andrew  Newswire.com

New to The Street Broadcasts Show #716 Tonight at 6:30 PM ET on Bloomberg Television Featuring Stardust Power (NASDAQ:SDST), BioVie (NASDAQ:BIVI), Roadzen (NASDAQ:RDZN), with Special Segments from Kelsey Grammer on KAREN and Andrew - Newswire.com

Click here to get full coverage on BioVie Files for a Stock Offering - Moomoo

BioVie Files for a Stock Offering  Moomoo

BioVie Files for a Stock Offering - Moomoo

Click here to get full coverage on BioVie Inc (BIVI) Valuation: PE, PB & Fair Value Analysis - TradingKey

BioVie Inc (BIVI) Valuation: PE, PB & Fair Value Analysis  TradingKey

BioVie Inc (BIVI) Valuation: PE, PB & Fair Value Analysis - TradingKey

Click here to get full coverage on Biovie CFO Joanne Kim buys $5,450 in Biovie Inc. stock - Investing.com

Biovie CFO Joanne Kim buys $5,450 in Biovie Inc. stock  Investing.com

Biovie CFO Joanne Kim buys $5,450 in Biovie Inc. stock - Investing.com

Click here to get full coverage on Terra Nova Jupiter Lite Bivi | Tested and reviewed - Live for the Outdoors

Terra Nova Jupiter Lite Bivi | Tested and reviewed  Live for the Outdoors

Terra Nova Jupiter Lite Bivi | Tested and reviewed - Live for the Outdoors

Click here to get full coverage on BioVie to highlight neuro and liver disease programs in June 2 investor webinar - Proactive financial news

BioVie to highlight neuro and liver disease programs in June 2 investor webinar  Proactive financial news

BioVie to highlight neuro and liver disease programs in June 2 investor webinar - Proactive financial news

Click here to get full coverage on We tested the Lifesystems Hooped Bivi, hoping it’s the affordable shelter so many backpackers want - Live for the Outdoors

We tested the Lifesystems Hooped Bivi, hoping it’s the affordable shelter so many backpackers want  Live for the Outdoors

We tested the Lifesystems Hooped Bivi, hoping it’s the affordable shelter so many backpackers want - Live for the Outdoors

Click here to get full coverage on BioVie completes enrollment in Long COVID trial as need for treatments grows - Proactive financial news

BioVie completes enrollment in Long COVID trial as need for treatments grows  Proactive financial news

BioVie completes enrollment in Long COVID trial as need for treatments grows - Proactive financial news

Click here to get full coverage on BioVie (BIVI) Shares: Moves 9.74% Up to $2.14 in the Latest Session; Boundary Watch - siam.in

BioVie (BIVI) Shares: Moves 9.74% Up to $2.14 in the Latest Session; Boundary Watch  siam.in

BioVie (BIVI) Shares: Moves 9.74% Up to $2.14 in the Latest Session; Boundary Watch - siam.in

Click here to get full coverage on BioVie advances long COVID trial, top-line data expected by summer - Proactive financial news

BioVie advances long COVID trial, top-line data expected by summer  Proactive financial news

BioVie advances long COVID trial, top-line data expected by summer - Proactive financial news

Click here to get full coverage on UK Kai mahngay Tareen Apparment Sai Mia Bivi Aur 9 sala Baitay nai chalang Laga Di || Overseas Story - YouTube

UK Kai mahngay Tareen Apparment Sai Mia Bivi Aur 9 sala Baitay nai chalang Laga Di || Overseas Story  YouTube

UK Kai mahngay Tareen Apparment Sai Mia Bivi Aur 9 sala Baitay nai chalang Laga Di || Overseas Story - YouTube

Click here to get full coverage on BioVie (BIVI) Financial Update: Profit Per Share Surpasses Its Benchmark in Latest Trading; Share Response: Shares Close 38.81% Higher on the Day - Weak Earnings Momentum - vinanet.vn

BioVie (BIVI) Financial Update: Profit Per Share Surpasses Its Benchmark in Latest Trading; Share Response: Shares Close 38.81% Higher on the Day - Weak Earnings Momentum  vinanet.vn

BioVie (BIVI) Financial Update: Profit Per Share Surpasses Its Benchmark in Latest Trading; Share Response: Shares Close 38.81% Higher on the Day - Weak Earnings Momentum - vinanet.vn

Click here to get full coverage on BioVie (BIVI) Shares: Moves 9.74% Up to $2.14 in the Latest Session; Boundary Watch - dars.gov.et

BioVie (BIVI) Shares: Moves 9.74% Up to $2.14 in the Latest Session; Boundary Watch  dars.gov.et

BioVie (BIVI) Shares: Moves 9.74% Up to $2.14 in the Latest Session; Boundary Watch - dars.gov.et

Click here to get full coverage on BioVie Inc. (BIVI) Q2 2026 Earnings: Narrower-Than-Expected Loss as Biotech Advances Clinical Pipeline - vinanet.vn

BioVie Inc. (BIVI) Q2 2026 Earnings: Narrower-Than-Expected Loss as Biotech Advances Clinical Pipeline  vinanet.vn

BioVie Inc. (BIVI) Q2 2026 Earnings: Narrower-Than-Expected Loss as Biotech Advances Clinical Pipeline - vinanet.vn

Click here to get full coverage on Biovie CFO Joanne Kim buys $5,450 in Biovie Inc. stock By Investing.com - Investing.com India

Biovie CFO Joanne Kim buys $5,450 in Biovie Inc. stock By Investing.com  Investing.com India

Biovie CFO Joanne Kim buys $5,450 in Biovie Inc. stock By Investing.com - Investing.com India

Click here to get full coverage on BioVie Inc. (BIVI) Q1 2026 Earnings: Narrower-than-Expected Loss as Clinical Pipeline Advances - Revenue Growth Report - dars.gov.et

BioVie Inc. (BIVI) Q1 2026 Earnings: Narrower-than-Expected Loss as Clinical Pipeline Advances - Revenue Growth Report  dars.gov.et

BioVie Inc. (BIVI) Q1 2026 Earnings: Narrower-than-Expected Loss as Clinical Pipeline Advances - Revenue Growth Report - dars.gov.et

Click here to get full coverage on Best Backpacking Bivvy Bags For 2026 - outdoorsmagic.com

Best Backpacking Bivvy Bags For 2026  outdoorsmagic.com

Best Backpacking Bivvy Bags For 2026 - outdoorsmagic.com

Click here to get full coverage on BioVie Inc (BIVI) sentiment score, message volume, participation score and buzz level - Stocktwits

BioVie Inc (BIVI) sentiment score, message volume, participation score and buzz level  Stocktwits

BioVie Inc (BIVI) sentiment score, message volume, participation score and buzz level - Stocktwits

Click here to get full coverage on BioVie (BIVI) Financial Update: Profit Per Share Surpasses Its Benchmark in Latest Trading - dars.gov.et

BioVie (BIVI) Financial Update: Profit Per Share Surpasses Its Benchmark in Latest Trading  dars.gov.et

BioVie (BIVI) Financial Update: Profit Per Share Surpasses Its Benchmark in Latest Trading - dars.gov.et

Click here to get full coverage on BioVie Inc. (BIVI) Holds Steady at $1.56 as Shares Consolidate Between Key Support and Resistance - ETF Liquidity - dars.gov.et

BioVie Inc. (BIVI) Holds Steady at $1.56 as Shares Consolidate Between Key Support and Resistance - ETF Liquidity  dars.gov.et

BioVie Inc. (BIVI) Holds Steady at $1.56 as Shares Consolidate Between Key Support and Resistance - ETF Liquidity - dars.gov.et

Click here to get full coverage on BIVI Q1 2026 Earnings: Narrower-Than-Expected Loss but Stock Declines on No Revenue Stream - Financial Health Score - dars.gov.et

BIVI Q1 2026 Earnings: Narrower-Than-Expected Loss but Stock Declines on No Revenue Stream - Financial Health Score  dars.gov.et

BIVI Q1 2026 Earnings: Narrower-Than-Expected Loss but Stock Declines on No Revenue Stream - Financial Health Score - dars.gov.et

Click here to get full coverage on BioVie Inc. (BIVI) reports earnings - qz.com

BioVie Inc. (BIVI) reports earnings  qz.com

BioVie Inc. (BIVI) reports earnings - qz.com

Click here to get full coverage on BIVI Q1 2026 Earnings: EPS Beats Estimates as Drug Development Progresses - Upward Estimate Revision - dars.gov.et

BIVI Q1 2026 Earnings: EPS Beats Estimates as Drug Development Progresses - Upward Estimate Revision  dars.gov.et

BIVI Q1 2026 Earnings: EPS Beats Estimates as Drug Development Progresses - Upward Estimate Revision - dars.gov.et

Click here to get full coverage on Lifesystems Heatshield Thermal Bivi Bag review - TGO Magazine

Lifesystems Heatshield Thermal Bivi Bag review  TGO Magazine

Lifesystems Heatshield Thermal Bivi Bag review - TGO Magazine

Click here to get full coverage on BIVI Q1 2026 Earnings: EPS Beat Amid Clinical Progress; Stock Declines - Tech Earnings Analysis - dars.gov.et

BIVI Q1 2026 Earnings: EPS Beat Amid Clinical Progress; Stock Declines - Tech Earnings Analysis  dars.gov.et

BIVI Q1 2026 Earnings: EPS Beat Amid Clinical Progress; Stock Declines - Tech Earnings Analysis - dars.gov.et

Click here to get full coverage on BioVie Inc. (BIVI) Q1 2026 Earnings: Narrower-than-Expected Loss Provides Modest Relief as Stock Declines - Downward Estimate Revision - dars.gov.et

BioVie Inc. (BIVI) Q1 2026 Earnings: Narrower-than-Expected Loss Provides Modest Relief as Stock Declines - Downward Estimate Revision  dars.gov.et

BioVie Inc. (BIVI) Q1 2026 Earnings: Narrower-than-Expected Loss Provides Modest Relief as Stock Declines - Downward Estimate Revision - dars.gov.et

Click here to get full coverage on BioVie Inc. (BIVI) Q1 2026 Earnings: EPS Surpasses Estimates Despite Ongoing Revenue Void - Earnings Growth Analysis - dars.gov.et

BioVie Inc. (BIVI) Q1 2026 Earnings: EPS Surpasses Estimates Despite Ongoing Revenue Void - Earnings Growth Analysis  dars.gov.et

BioVie Inc. (BIVI) Q1 2026 Earnings: EPS Surpasses Estimates Despite Ongoing Revenue Void - Earnings Growth Analysis - dars.gov.et

Click here to get full coverage on BIVI Q1 2026 Earnings: EPS Beats Estimates Despite No Revenue, Stock Drops - Management Tone Analysis - dars.gov.et

BIVI Q1 2026 Earnings: EPS Beats Estimates Despite No Revenue, Stock Drops - Management Tone Analysis  dars.gov.et

BIVI Q1 2026 Earnings: EPS Beats Estimates Despite No Revenue, Stock Drops - Management Tone Analysis - dars.gov.et

Click here to get full coverage on BioVie Inc. (BIVI) Q1 2026 Earnings: Narrower Loss Per Share Fails to Inspire; Stock Slides 7% - Analyst Drop Coverage - dars.gov.et

BioVie Inc. (BIVI) Q1 2026 Earnings: Narrower Loss Per Share Fails to Inspire; Stock Slides 7% - Analyst Drop Coverage  dars.gov.et

BioVie Inc. (BIVI) Q1 2026 Earnings: Narrower Loss Per Share Fails to Inspire; Stock Slides 7% - Analyst Drop Coverage - dars.gov.et

Click here to get full coverage on BIVI Stock Price and Chart — NASDAQ:BIVI - TradingView

BIVI Stock Price and Chart — NASDAQ:BIVI  TradingView

BIVI Stock Price and Chart — NASDAQ:BIVI - TradingView

Click here to get full coverage on RAB Trailhead Bivi review: a no-fuss bivy ideal for minimalist nights out - Advnture

RAB Trailhead Bivi review: a no-fuss bivy ideal for minimalist nights out  Advnture

BIVI

Price Chart

Key Statistics

Technicals

About BIVI

Latest News

Biovie Stock Price Forecast. Should You Buy BIVI? - StockInvest.us

Cumulus Mosquito Bivi Review: Cowboy Glamping - bikepacking.com

Jane Street Group Expands BioVie Inc (BIVI) Stake by Over 1,100% - GuruFocus

Advanced Charts

Top Gainers

Top Losers